November 3, 2026 · JACC. Cardiovascular interventions · DOI: 10.1016/j.jcin.2026.10.020

3-Year Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Artery Disease: The SIRONA Trial.

Listen to this summary

The SIRONA randomized trial asked whether sirolimus-coated balloons (SCB) offer better outcomes than paclitaxel-coated balloons (PCB) for symptomatic femoropopliteal artery disease over 3 years. Among 482 patients, walking capacity, quality of life, mortality, amputation, and amputation-free survival did not differ between groups, though freedom from clinically driven target lesion revascularization was higher with SCB (88.2% vs. 80.2%, HR 0.60). Because this 3-year cdTLR finding was exploratory and not adjusted for multiple comparisons, and the treatment effect appeared to vary over time, it requires confirmation.

Ulf Teichgräber, Maja Ingwersen, Thomas Lehmann, Stephanie Platzer, Ina Kunstmann, Sabine Steiner, Andrej Schmidt, Tim Wittig, Thomas Zeller, Marcus Thieme, Hans Krankenberg, Martin Werner, Marianne Brodmann, Nasser Malyar, Stefan Müller-Hülsbeck, Luca de Paoli, Oliver Schlager, Martin Austermann, Gunnar Tepe, Christian Erbel, Wulf Ito, Rainer Waßmer, Lars Maiwald, René Aschenbach, Christian Wissgott, Martin Andrassy, Florian Wolf, Ulrich Beschorner, Maciej Pech, Konstantinos Katsanos, Dierk Scheinert

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play